Tofogliflozin GLP-1 Analogue Combination Trial

NCT02537834 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Tofogliflozin
DRUG: GLP-1 analogue

Sponsor

Kowa Company, Ltd.

Collaborators

[object Object]